A clinically relevant model of osteoinduction: A process requiring calcium phosphate and BMP/Wnt signalling

Journal of Cellular and Molecular Medicine

Volumn 14, Issue 6 B, 2010, Pages 1845-1856

  Eyckmans, J ^a   Roberts, S J ^a   Schrooten, J ^a   Luyten, F P ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Bone morphogenetic protein; Calcium phosphate; Mechanism of action; Osteoinduction; Periosteum derived cell; Tissue engineering; Wnt signalling

Indexed keywords

BETA-TRICALCIUM PHOSPHATE; BONE MORPHOGENETIC PROTEIN; CALCIUM PHOSPHATE; CARRIER PROTEIN; COLLAGEN; COLLAGRAFT; FRZB PROTEIN; GLYCOPROTEIN; HYDROXYAPATITE; NOGGIN PROTEIN; WNT PROTEIN;

ADOLESCENT; ADULT; ANIMAL; ARTICLE; BIOLOGICAL MODEL; BONE DEVELOPMENT; CELL COUNT; CELL PROLIFERATION; CHORISTOMA; CYTOLOGY; DOWN REGULATION; DRUG EFFECT; FEMALE; HUMAN; MALE; METABOLISM; MOUSE; PATHOLOGY; PERIOSTEUM; SIGNAL TRANSDUCTION;

ADOLESCENT; ADULT; ANIMALS; BONE MORPHOGENETIC PROTEINS; CALCIUM PHOSPHATES; CARRIER PROTEINS; CELL COUNT; CELL PROLIFERATION; CHORISTOMA; COLLAGEN; DOWN-REGULATION; DURAPATITE; FEMALE; GLYCOPROTEINS; HUMANS; MALE; MICE; MODELS, BIOLOGICAL; OSTEOGENESIS; PERIOSTEUM; SIGNAL TRANSDUCTION; WNT PROTEINS; YOUNG ADULT;

ADENOVIRIDAE; MUS;

EID: 77955163096     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2009.00807.x     Document Type: Article

References (63)

1. Zhu L, Liu W, Cui L. Tissue-engineered bone repair of goat-femur defects with osteogenically induced bone marrow stromal cells. Tissue Eng. 2006, 12:423-33.
2. Yuan J, Cui L, Zhang WJ. Repair of canine mandibular bone defects with bone marrow stromal cells and porous beta-tricalcium phosphate. Biomaterials. 2007, 28:1005-13.
3. Petite H, Viateau V, Bensaid W. Tissue-engineered bone regeneration. Nat Biotechnol. 2000, 18:959-63.
4. Quarto R, Mastrogiacomo M, Cancedda R. Repair of large bone defects with the use of autologous bone marrow stromal cells. N Engl J Med. 2001, 344:385-6.
5. Marcacci M, Kon E, Moukhachev V. Stem cells associated with macroporous bioceramics for long bone repair: 6- to 7-year outcome of a pilot clinical study. Tissue Eng. 2007, 13:947-55.
6. Viateau V, Guillemin G, Bousson V. Long-bone critical-size defects treated with tissue-engineered grafts: a study on sheep. J Orthop Res. 2007, 25:741-9.
7. Eyckmans J, Luyten FP. Species specificity of ectopic bone formation using periosteum-derived mesenchymal progenitor cells. Tissue Eng. 2006, 12:2203-13.
8. Hartman EH, Vehof JW, Spauwen PH, Jansen JA. Ectopic bone formation in rats: the importance of the carrier. Biomaterials. 2005, 26:1829-35.
9. Yuan H, Blitterswijk CA, Groot KD, Bruijn JD. Cross-species comparison of ectopic bone formation in biphasic calcium phosphate (BCP) and hydroxyapatite (HA) scaffolds. Tissue Eng. 2006, 12:1607-15.
10. Cancedda R, Mastrogiacomo M, Bianchi G. Bone marrow stromal cells and their use in regenerating bone. Novartis Found Symp. 2003, 249:133-43.
11. Kruyt MC, De Bruijn JD, Wilson CE. Viable osteogenic cells are obligatory for tissue-engineered ectopic bone formation in goats. Tissue Eng. 2003, 9:327-36.
12. Kuznetsov SA, Krebsbach PH, Satomura K. Single-colony derived strains of human marrow stromal fibroblasts form bone after transplantation in vivo. J Bone Miner Res. 1997, 12:1335-47.
13. Dieudonne SC, Kerr JM, Xu T. Differential display of human marrow stromal cells reveals unique mRNA expression patterns in response to dexamethasone. J Cell Biochem. 1999, 76:231-43.
14. Nakahara H, Goldberg VM, Caplan AI. Culture-expanded periosteal-derived cells exhibit osteochondrogenic potential in porous calcium phosphate ceramics in vivo. Clin Orthop. 1992, 276:291-8.
15. Dell'Accio F, De Bari C, Neys J, Luyten FP. Multipotent cell populations from adult human articular cartilage. Arthritis Rheum. 2001, 44:S61.
16. De Bari C, Dell'Accio F, Vanlauwe J. Mesenchymal multipotency of adult human periosteal cells demonstrated by single-cell lineage analysis. Arthritis Rheum. 2006, 54:1209-21.
17. Hicok KC, Du Laney TV, Zhou YS. Human adipose-derived adult stem cells produce osteoid in vivo. Tissue Eng. 2004, 10:371-80.
18. Dai W, Dong J, Fang T, Uemura T. Stimulation of osteogenic activity in mesenchymal stem cells by FK506. J Biomed Mater Res A. 2008, 86:235-43.
19. Yoshikawa T, Nakajima H, Yamada E. In vivo osteogenic capability of cultured allogeneic bone in porous hydroxyapatite: immunosuppressive and osteogenic potential of FK506 in vivo. J Bone Miner Res. 2000, 15:1147-57.
20. Habibovic P, de Groot K. Osteoinductive biomaterials-properties and relevance in bone repair. J Tissue Eng Regen Med. 2007, 1:25-32.
21. Harris CT, Cooper LF. Comparison of bone graft matrices for human mesenchymal stem cell-directed osteogenesis. J Biomed Mater Res A. 2004, 68:747-55.
22. Zhu SJ, Choi BH, Huh JY. A comparative qualitative histological analysis of tissue-engineered bone using bone marrow mesenchymal stem cells, alveolar bone cells, and periosteal cells. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006, 101:164-9.
23. Chang SC, Chuang H, Chen YR. Cranial repair using BMP-2 gene engineered bone marrow stromal cells. J Surg Res. 2004, 119:85-91.
24. Dragoo JL, Choi JY, Lieberman JR. Bone induction by BMP-2 transduced stem cells derived from human fat. J Orthop Res. 2003, 21:622-9.
25. Hidaka C, Goshi K, Rawlins B. Enhancement of spine fusion using combined gene therapy and tissue engineering BMP-7-expressing bone marrow cells and allograft bone. Spine. 2003, 28:2049-57.
26. Noel D, Gazit D, Bouquet C. Short-term BMP-2 expression is sufficient for in vivo osteochondral differentiation of mesenchymal stem cells. Stem Cells. 2004, 22:74-85.
27. Habibovic P, Yuan H, van der Valk CM. 3D microenvironment as essential element for osteoinduction by biomaterials. Biomaterials. 2005, 26:3565-75.
28. Habibovic P, Sees TM, van den Doel MA. Osteoinduction by biomaterials-physicochemical and structural influences. J Biomed Mater Res A. 2006, 77:747-62.
29. Khlusov IA, Karlov AV, Sharkeev YP. Osteogenic potential of mesenchymal stem cells from bone marrow in situ: role of physicochemical properties of artificial surfaces. Bull Exp Biol Med. 2005, 140:144-52.
30. Stevens MM, Marini RP, Schaefer D. In vivo engineering of organs: the bone bioreactor. Proc Natl Acad Sci USA. 2005, 102:11450-5.
31. De Bari C, Dell'Accio F, Luyten FP. Human periosteum-derived cells maintain phenotypic stability and chondrogenic potential throughout expansion regardless of donor age. Arthritis Rheum. 2001, 44:85-95.
32. Martin I, Mastrogiacomo M, De Leo G. Fluorescence microscopy imaging of bone for automated histomorphometry. Tissue Eng. 2002, 8:847-52.
33. Hatano H, Tokunaga K, Ogose A. Origin of bone-forming cells in human osteosarcomas transplanted into nude mice-which cells produce bone, human or mouse. J Pathol. 1998, 185:204-11.
34. De Bari C, Dell'Accio F, Vandenabeele F. Skeletal muscle repair by adult human mesenchymal stem cells from synovial membrane. J Cell Biol. 2003, 160:909-18.
35. Wozney JM, Rosen V, Celeste AJ. Novel regulators of bone formation: molecular clones and activities. Science. 1988, 242:1528-34.
36. Urist MR. Bone: formation by autoinduction. Science. 1965, 150:893-9.
37. Day TF, Guo X, Garrett-Beal L, Yang Y. Wnt/beta-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis. Dev Cell. 2005, 8:739-50.
38. Mak KK, Chen MH, Day TF. Wnt/beta-catenin signaling interacts differentially with Ihh signaling in controlling endochondral bone and synovial joint formation. Development. 2006, 133:3695-707.
39. Sieunarine K, Lawrence-Brown MM. Arteriovenous fistula: a rare complication after iliac bone graft. Cardiovasc Surg. 1993, 1:734-5.
40. Murata Y, Takahashi K, Yamagata M. Injury to the lateral femoral cutaneous nerve during harvest of iliac bone graft, with reference to the size of the graft. J Bone Joint Surg Br. 2002, 84:798-801.
41. Chan K, Resnick D, Pathria M, Jacobson J. Pelvic instability after bone graft harvesting from posterior iliac crest: report of nine patients. Skeletal Radiol. 2001, 30:278-81.
42. Mankani MH, Kuznetsov SA, Robey PG. Formation of hematopoietic territories and bone by transplanted human bone marrow stromal cells requires a critical cell density. Exp Hematol. 2007, 35:995-1004.
43. Sacchetti B, Funari A, Michienzi S. Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell. 2007, 131:324-36.
44. Foster BL, Nociti FH, Swanson EC. Regulation of cementoblast gene expression by inorganic phosphate in vitro. Calcif Tissue Int. 2006, 78:103-12.
45. Fatherazi S, Matsa-Dunn D, Foster BL. Phosphate regulates osteopontin gene transcription. J Dent Res. 2009, 88:39-44.
46. Rutherford RB, Foster BL, Bammler T. Extracellular phosphate alters cementoblast gene expression. J Dent Res. 2006, 85:505-9.
47. Nakade O, Takahashi K, Takuma T. Effect of extracellular calcium on the gene expression of bone morphogenetic protein-2 and -4 of normal human bone cells. J Bone Miner Metab. 2001, 19:13-9.
48. Raval P, Hsu HH, Schneider DJ. Expression of bone morphogenetic proteins by osteoinductive and non-osteoinductive human osteosarcoma cells. J Dent Res. 1996, 75:1518-23.
49. Siddappa R, Martens A, Doorn J. cAMP/PKA pathway activation in human mesenchymal stem cells in vitro results in robust bone formation in vivo. Proc Natl Acad Sci USA. 2008, 105:7281-6.
50. Ripamonti U. Osteoinduction in porous hydroxyapatite implanted in heterotopic sites of different animal models. Biomaterials. 1996, 17:31-5.
51. Zimmerman LB, Jesus-Escobar JM, Harland RM. The Spemann organizer signal noggin binds and inactivates bone morphogenetic protein 4. Cell. 1996, 86:599-606.
52. Groppe J, Greenwald J, Wiater E. Structural basis of BMP signalling inhibition by the cystine knot protein Noggin. Nature. 2002, 420:636-42.
53. Wang S, Krinks M, Lin K. Frzb, a secreted protein expressed in the Spemann organizer, binds and inhibits Wnt-8. Cell. 1997, 88:757-66.
54. Lin K, Wang S, Julius MA. The cysteine-rich frizzled domain of Frzb-1 is required and sufficient for modulation of Wnt signaling. Proc Natl Acad Sci USA. 1997, 94:11196-200.
55. Leyns L, Bouwmeester T, Kim SH. Frzb-1 is a secreted antagonist of Wnt signaling expressed in the Spemann organizer. Cell. 1997, 88:747-56.
56. Wawrzak D, Metioui M, Willems E. Wnt3a binds to several sFRPs in the nanomolar range. Biochem Biophys Res Commun. 2007, 357:1119-23.
57. Scardigli R, Gargioli C, Tosoni D. Binding of sFRP-3 to EGF in the extra-cellular space affects proliferation, differentiation and morphogenetic events regulated by the two molecules. PLoS ONE. 2008, 3:e2471.
58. Ille F, Atanasoski S, Falk S. Wnt/BMP signal integration regulates the balance between proliferation and differentiation of neuroepithelial cells in the dorsal spinal cord. Dev Biol. 2007, 304:394-408.
59. Minina E, Wenzel HM, Kreschel C. BMP and Ihh/PTHrP signaling interact to coordinate chondrocyte proliferation and differentiation. Development. 2001, 128:4523-34.
60. Shum L, Wang X, Kane AA, Nuckolls GH. BMP4 promotes chondrocyte proliferation and hypertrophy in the endochondral cranial base. Int J Dev Biol. 2003, 47:423-31.
61. Suzuki Y, Montagne K, Nishihara A. BMPs promote proliferation and migration of endothelial cells via stimulation of VEGF-A/VEGFR2 and angiopoietin-1/Tie2 signalling. J Biochem. 2008, 143:199-206.
62. ten Berge D, Brugmann SA, Helms JA, Nusse R. Wnt and FGF signals interact to coordinate growth with cell fate specification during limb development. Development. 2008, 135:3247-57.
63. Liu G, Vijayakumar S, Grumolato L. Canonical Wnts function as potent regulators of osteogenesis by human mesenchymal stem cells. J Cell Biol. 2009, 185:67-75.